Drug Profile
Research programme: dyslipidaemia therapy - Dr Reddy's
Alternative Names: DRL-12424Latest Information Update: 03 Aug 2010
Price :
$50
*
At a glance
- Originator Dr Reddys Laboratories
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Lipid metabolism disorders
Most Recent Events
- 18 Apr 2007 Preclinical trials in Lipid metabolism disorders in India (unspecified route)